Banned Words at FDA; Top Cancer Center Halts DEI Initiatives; ‘End Childhood Cancer’

“Woman,” “elderly,” and “disabled” were among a list of banned words reportedly circulating within the FDA, which the White House called a misinterpretation of an executive order. (Reuters via Yahoo!)

Samsung Bioepis announced FDA approval of Ospomyv and Xbryk, biosimilars referencing denosumab (Prolia, Xgeva).

Outcomes in metastatic bladder cancer improved in men who received antihistamines in addition to immunotherapy. (University of Cincinnati)

Hundreds of federal jobs funded by private sources, not taxpayers — including those at the FDA that affect medical device approval — have been included in the Trump administration’s workforce reduction, raising questions about the cuts’ budget impact. (Reuters)

Citing $400 million in federal funding at risk, Fred Hutch Cancer Center in Seattle announced the end of its diversity, equity, and inclusion (DEI) initiatives in response to a Trump administration executive order. (Seattle Times)

Faced with a lawsuit alleging racial discrimination, the University of Colorado School of Medicine dropped a “historically underrepresented in medicine” requirement from a scholarship program. (CPR News)

Cryotherapy significantly reduced the frequency of chemotherapy-induced peripheral neuropathy in patients with breast cancer, according to a meta-analysis of published studies. (George Washington University)

ImmunityBio announced FDA authorization of an expanded access program to increase availability of recombinant bacillus Calmette-Guérin, a commonly used treatment for bladder cancer, which has been in short supply.

Neoadjuvant therapy that included nivolumab (Opdivo) significantly improved overall survival in resectable non-small cell lung cancer versus chemotherapy, Bristol Myers Squibb announced.

In a first-of-its-kind collaboration, Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center announced a joint venture to “end childhood cancer.”

A drug-discovery program supported by artificial intelligence discovered multiple abandoned or discontinued drugs that show promise for ovarian cancer, according to a statement from Predictive Oncology.

New data from the American Cancer Society (ACS) show that cancer mortality among Black people has declined but remains higher as compared with white people or those in other ethnic groups.

A British study showed that cancer mortality is 60% higher among people living in the most deprived areas versus the least deprived. (Cancer Research UK)

Another ACS study showed that almost half of patients with advanced cancer received potentially aggressive care at the end of life at the expense of supportive care.

In a win against “time toxicity,” a simple messaging system shaved an hour off the time required for a cancer treatment visit. (Penn Medicine)

Please enable JavaScript to view the

comments powered by Disqus.